These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17717832)

  • 1. [Prediction of plasma protein binding of cephalosporins from polar molecular surface areas].
    Fu XC; Ke F; Zhan SY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):386-90. PubMed ID: 17717832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of plasma protein binding of cephalosporins using an artificial neural network.
    Fu XC; Wang GP; Gao JQ; Zhan SY; Liang WQ
    Pharmazie; 2007 Feb; 62(2):157-8. PubMed ID: 17341040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of human intestinal absorption from net polar atomic charges of drug molecules].
    Fu XC; Zhan SY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):199-203. PubMed ID: 16610089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between absorption rates of beta-adrenoreceptor antagonists in rat small intestine and their molecular structures].
    Fu XC; Sun Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):177-80. PubMed ID: 15812895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting blood-brain barrier penetration of drugs by polar molecular surface area and molecular volume.
    Fu XC; Chen CX; Liang WQ; Yu QS
    Acta Pharmacol Sin; 2001 Jul; 22(7):663-8. PubMed ID: 11749834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of percutaneous drug permeability using modified theoretical linear solvation energy relationship].
    Fu XC; Dai YW
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):352-5. PubMed ID: 12970943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method to predict the elimination half-lives and the renal excretion mechanisms of cephalosporins.
    Komiya I; Nishio M; Murata S; Chiba F; Sakurai T; Shinkai S; Fujita M
    J Pharmacobiodyn; 1984 Aug; 7(8):545-55. PubMed ID: 6512677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some determinants of the distribution of penicillins and cephalosporins in the body. Practical and theoretical considerations.
    Barza M; Weinstein L
    Ann N Y Acad Sci; 1974 May; 235(0):613-20. PubMed ID: 4527978
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of cefpiramide in the plasma of various species.
    Ohshima T; Hasegawa T; Johno I; Kitazawa S
    J Pharm Pharmacol; 1991 Nov; 43(11):805-6. PubMed ID: 1686912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin.
    Nerli B; Romanini D; Picó G
    Chem Biol Interact; 1997 May; 104(2-3):179-202. PubMed ID: 9212783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans.
    Hoffstedt B; Walder M
    Antimicrob Agents Chemother; 1981 Dec; 20(6):783-6. PubMed ID: 7325644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the interaction of cephalosporins with blood serum proteins and organ homogenates].
    Klimova VS; Iakovlev VP
    Antibiotiki; 1979 Nov; 24(11):835-8. PubMed ID: 507778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum protein binding of cephalosporin antibiotics in vitro.
    Singhvi SM; Heald AF; Gadebusch HH; Resnick ME; Difazio LT; Leitz MA
    J Lab Clin Med; 1977 Feb; 89(2):414-20. PubMed ID: 833477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered disulfide bond between residues 69 and 238 in extended-spectrum beta-lactamase Toho-1 reduces its activity toward third-generation cephalosporins.
    Shimizu-Ibuka A; Matsuzawa H; Sakai H
    Biochemistry; 2004 Dec; 43(50):15737-45. PubMed ID: 15595829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of trypsin specificity based on QM/MM molecular dynamics simulation and QM/MM GBSA calculation.
    Chen J; Wang J; Zhang Q; Chen K; Zhu W
    J Biomol Struct Dyn; 2015; 33(12):2606-18. PubMed ID: 25562613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations.
    Gray JJ; Moughon S; Wang C; Schueler-Furman O; Kuhlman B; Rohl CA; Baker D
    J Mol Biol; 2003 Aug; 331(1):281-99. PubMed ID: 12875852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific cephalosporin-binding protein of Citrobacter freundii.
    Ogawara H
    Biochim Biophys Acta; 1976 Jan; 420(1):155-64. PubMed ID: 1247578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.